Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

Antoni Ribas; Alain Algazi; Paolo A. Ascierto; Marcus O. Butler; Sunandana Chandra; Michael Gordon; Leonel Hernandez-Aya; Donald Lawrence; Jose Lutzky; Wilson H. Miller; Katie M. Campbell; Bruno Delafont; Shannon Marshall; Nancy Mueller; Caroline Robert

doi:10.1038/s41467-021-25285-0

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

Antoni Ribas, Alain Algazi, Paolo A. Ascierto, Marcus O. Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H. Miller, Katie M. Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

Résumé

There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

langue originale	Anglais
Numéro d'article	5022
journal	Nature Communications
Volume	12
Numéro de publication	1
Les DOIs	https://doi.org/10.1038/s41467-021-25285-0
état	Publié - 1 déc. 2021

Accès au document

10.1038/s41467-021-25285-0

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Ribas, A., Algazi, A., Ascierto, P. A., Butler, M. O., Chandra, S., Gordon, M., Hernandez-Aya, L., Lawrence, D., Lutzky, J., Miller, W. H., Campbell, K. M., Delafont, B., Marshall, S., Mueller, N., & Robert, C. (2021). Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w). Nature Communications, 12(1), Article 5022. https://doi.org/10.1038/s41467-021-25285-0

@article{7caa91546c3244989fb1b6432fdefc0f,

title = "Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)",

abstract = "There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state {\textquoteleft}Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures{\textquoteright}. The PDF and HTML versions of the Article have been updated.",

author = "Antoni Ribas and Alain Algazi and Ascierto, {Paolo A.} and Butler, {Marcus O.} and Sunandana Chandra and Michael Gordon and Leonel Hernandez-Aya and Donald Lawrence and Jose Lutzky and Miller, {Wilson H.} and Campbell, {Katie M.} and Bruno Delafont and Shannon Marshall and Nancy Mueller and Caroline Robert",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = dec,

day = "1",

doi = "10.1038/s41467-021-25285-0",

language = "English",

volume = "12",

journal = "Nature Communications",

issn = "2041-1723",

number = "1",

}

Ribas, A, Algazi, A, Ascierto, PA, Butler, MO, Chandra, S, Gordon, M, Hernandez-Aya, L, Lawrence, D, Lutzky, J, Miller, WH, Campbell, KM, Delafont, B, Marshall, S, Mueller, N & Robert, C 2021, 'Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)', Nature Communications, VOL. 12, Numéro 1, 5022. https://doi.org/10.1038/s41467-021-25285-0

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w). / Ribas, Antoni; Algazi, Alain; Ascierto, Paolo A. et al.
Dans: Nature Communications, Vol 12, Numéro 1, 5022, 01.12.2021.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Author Correction

T2 - PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (Nature Communications, (2020), 11, 1, (6262), 10.1038/s41467-020-19810-w)

AU - Ribas, Antoni

AU - Algazi, Alain

AU - Ascierto, Paolo A.

AU - Butler, Marcus O.

AU - Chandra, Sunandana

AU - Gordon, Michael

AU - Hernandez-Aya, Leonel

AU - Lawrence, Donald

AU - Lutzky, Jose

AU - Miller, Wilson H.

AU - Campbell, Katie M.

AU - Delafont, Bruno

AU - Marshall, Shannon

AU - Mueller, Nancy

AU - Robert, Caroline

PY - 2021/12/1

Y1 - 2021/12/1

N2 - There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

AB - There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.

UR - http://www.scopus.com/inward/record.url?scp=85112731032&partnerID=8YFLogxK

U2 - 10.1038/s41467-021-25285-0

DO - 10.1038/s41467-021-25285-0

M3 - Comment/debate

C2 - 34385448

AN - SCOPUS:85112731032

SN - 2041-1723

VL - 12

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 5022

ER -